1. Home
  2. GNFT vs TLS Comparison

GNFT vs TLS Comparison

Compare GNFT & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • TLS
  • Stock Information
  • Founded
  • GNFT 1999
  • TLS 1969
  • Country
  • GNFT France
  • TLS United States
  • Employees
  • GNFT N/A
  • TLS N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • TLS EDP Services
  • Sector
  • GNFT Health Care
  • TLS Technology
  • Exchange
  • GNFT Nasdaq
  • TLS Nasdaq
  • Market Cap
  • GNFT 249.0M
  • TLS 259.4M
  • IPO Year
  • GNFT 2019
  • TLS 2020
  • Fundamental
  • Price
  • GNFT $6.06
  • TLS $3.54
  • Analyst Decision
  • GNFT Strong Buy
  • TLS Buy
  • Analyst Count
  • GNFT 1
  • TLS 6
  • Target Price
  • GNFT $13.00
  • TLS $4.50
  • AVG Volume (30 Days)
  • GNFT 26.3K
  • TLS 386.8K
  • Earning Date
  • GNFT 09-19-2024
  • TLS 11-07-2024
  • Dividend Yield
  • GNFT N/A
  • TLS N/A
  • EPS Growth
  • GNFT N/A
  • TLS N/A
  • EPS
  • GNFT 0.47
  • TLS N/A
  • Revenue
  • GNFT $86,225,222.00
  • TLS $135,362,000.00
  • Revenue This Year
  • GNFT $155.44
  • TLS N/A
  • Revenue Next Year
  • GNFT N/A
  • TLS $43.60
  • P/E Ratio
  • GNFT $12.34
  • TLS N/A
  • Revenue Growth
  • GNFT 175.45
  • TLS N/A
  • 52 Week Low
  • GNFT $2.97
  • TLS $1.89
  • 52 Week High
  • GNFT $6.08
  • TLS $5.03
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 69.91
  • TLS 53.09
  • Support Level
  • GNFT $5.41
  • TLS $3.39
  • Resistance Level
  • GNFT $5.84
  • TLS $3.60
  • Average True Range (ATR)
  • GNFT 0.30
  • TLS 0.17
  • MACD
  • GNFT 0.04
  • TLS -0.00
  • Stochastic Oscillator
  • GNFT 98.03
  • TLS 64.58

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

Share on Social Networks: